Abstract
Abstract Immune responses during pregnancy need to be precisely regulated to protect the fetus from microbial infections and to maintain tolerance for the semi-allogeneic fetus. However, the mechanisms regulating fetal tolerance during pregnancy are not well understood. Recently we have identified KIR +CD8 +T cells as a previously unappreciated subset with regulatory functions in humans to suppress harmful self-reactivity. Therefore, we asked whether KIR +CD8 +T cells also play a role in inducing immune tolerance during pregnancy. We first observed an increased frequency of KIR +CD8 +T cells, but not CD4 +regulatory T cells (Tregs), in the peripheral blood of pregnant women at second trimester compared to age-matched nonpregnant females. Interestingly, those with a male fetus had an even higher level of KIR +CD8 +T cells than the ones with a female fetus. In vitro, we found that KIR +CD8 +T cells can suppress CD8 +T cells specific to H-Y antigens (encoded by the Y chromosome) only in mothers with a male fetus. Therefore, the higher induction of KIR +CD8 +T cells in mothers carrying a male fetus may suppress the additional allogenic immune responses triggered by the Y chromosome from the male fetus. Moreover, KIR +CD8 +T cells expand, lose memory features and gain cytotoxic capacity along gestation and their levels are maintained postpartum. In addition, we found the numbers of these suppressive CD8 +T cells correlated with pregnancy disorders, such as spontaneous abortion or pre-eclampsia. Taken together, our findings suggest an important role of KIR +CD8 +T cells in the maintenance of fetal tolerance by suppressing alloreactive fetus-specific T cells, therefore they may be useful as predictive biomarkers or drug targets for human pregnancy disorders. Supported by Howard Hughes Medical Institute.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.